Realistically, there’s a good chance your patients are using them to get GLP-1 agonists. And sometimes ... care process is the best course of action. We shouldn’t let a patient start with ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Association does not imply causation, and the mechanism of action of these agents ... of patients who filled a prescription for a GLP-1 within at least 90 days before and after surgery and ...

As Stacey Leasca reports for “Food & Wine,” research from Cornell University found that households with at least one GLP-1 user are significantly reducing their grocery spending. The paper ...

or GLP-1 receptor agonists, were originally solely intended for use as diabetes medications. However, they are now being used for a variety of purposes, including helping people with weight loss. The ...

The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based ... both have a long duration of action, allowing once-daily administration.